Biogen (BIIB) Financials
Biogen (BIIB) Historical Financial Statements and Key Metrics for 1991 - 2021
Full Biogen financials for 1991 - 2021 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Biogen Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2021-Mar-31 | 2,694 | 2,216 (82.3 %) | 1 (0.0 %) | 404 (15.0 %) | 147 | 2.57 |
| 2020-Dec-31 | 2,853 | 2,362 (82.8 %) | -486 (-17.0 %) | 358 (12.5 %) | -396 | 2.28 |
| 2020-Sep-30 | 3,376 | 2,927 (86.7 %) | 1,057 (28.4 %) | 702 (20.8 %) | 1,198 | 4.46 |
| 2020-Jun-30 | 3,682 | 3,270 (88.8 %) | 1,984 (55.3 %) | 1,542 (41.9 %) | 2,109 | 9.59 |
| 2020-Mar-31 | 3,534 | 3,080 (87.1 %) | 1,820 (51.5 %) | 1,399 (39.6 %) | 1,696 | 8.08 |
| 2019-Dec-31 | 3,671 | 3,224 (87.8 %) | 1,778 (48.4 %) | 1,440 (39.2 %) | 1,875 | 8.08 |
| 2019-Sep-30 | 3,600 | 3,170 (88.1 %) | 1,806 (50.2 %) | 1,546 (42.9 %) | 2,132 | 8.39 |
Full historical income statements for 1991 - 2021 is included in the
US Historical Financials dataset.
Biogen Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2021-Mar-31 | 23,854 | 13,191 | 7,267 | 10,682 | 2,537 |
| 2020-Dec-31 | 24,619 | 13,933 | 8,705 | 10,700 | 2,610 |
| 2020-Sep-30 | 24,934 | 14,190 | 7,834 | 10,758 | 3,580 |
| 2020-Jun-30 | 25,512 | 14,223 | 7,839 | 11,309 | 4,328 |
| 2020-Mar-31 | 26,119 | 13,572 | 5,962 | 12,547 | 3,860 |
| 2019-Dec-31 | 27,234 | 13,891 | 5,955 | 13,343 | 4,476 |
| 2019-Sep-30 | 27,484 | 13,488 | 5,954 | 13,996 | 4,437 |
Full historical balance sheet data for 1991 - 2021 is included in the
US Historical Financials dataset.
Biogen Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2021-Mar-31 | 769 | -64 | -785 | 677 |
| 2020-Dec-31 | -367 | -166 | -401 | -468 |
| 2020-Sep-30 | 1,181 | 0 | 0 | 1,097 |
| 2020-Jun-30 | 1,948 | 0 | 0 | 1,844 |
| 2020-Mar-31 | 1,467 | 443 | -2,245 | 1,206 |
| 2019-Dec-31 | 1,960 | 708 | -2,116 | 1,695 |
| 2019-Sep-30 | 1,695 | -366 | -689 | 1,605 |
Full historical cash flow data for 1991 - 2021 is included in the
US Historical Financials dataset.
Biogen Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2021-Mar-31 | 43,893 | 49,943 | 16.29 | 27.16 | 4.11 |
| 2020-Dec-31 | 38,419 | 44,514 | 13.47 | 26.84 | 3.59 |
| 2020-Sep-30 | 44,509 | 51,065 | 13.18 | 63.45 | 4.14 |
| 2020-Jun-30 | 42,969 | 49,950 | 11.67 | 27.86 | 3.80 |
| 2020-Mar-31 | 54,765 | 58,135 | 15.50 | 39.14 | 4.36 |
| 2019-Dec-31 | 52,877 | 55,918 | 14.40 | 36.73 | 3.96 |
| 2019-Sep-30 | 42,885 | 46,495 | 11.91 | 27.74 | 3.06 |
Full historical valuation and operating metrics for 1991 - 2021 are included in the
US Historical Financials dataset.